Literature DB >> 10987345

Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings.

A Suzuki1, S Miyagawa-Tomita, M Nakazawa, C Yutani.   

Abstract

Since the original report of Kawasaki disease in 1967 more than 150,000 cases have been reported in Japan. Although there have been no nationwide epidemics in Japan since 1987, more than 6,000 newly diagnosed cases are reported every year, and the number has been increasing year by year despite the decreasing birth rate. The etiology of the disease is still unknown. High dose intravenous gammaglobulin is currently used during the acute phase in 84% of the patients in Japan with a concomitant decrease in coronary arterial sequelae. However, 7-13% of the patients still have persistent coronary artery aneurysms after the acute stage. The aneurysms are seen mostly in the proximal coronary arteries, and are often associated with aneurysms in the distal coronary artery segments (Figure 1A, 2A). Most of the patients show a decrease in the size of aneurysms soon after the acute phase (Figure 1B). However, the aneurysms may progress to obstructive lesions even after initial regression (Figures 1C, D, 2B). Such obstructive lesions may cause sudden death or myocardial infarction. Long term follow-up of coronary artery lesions has revealed several characteristic features, including progressive localized stenosis (Figure 1D), extensive recanalizations (Figure 2D) and development of collateral arteries. Progressive increases in aneurysm size and the appearance of new aneurysms in the late phase have also been reported. The basic mechanisms of the coronary arterial remodeling in Kawasaki disease have not yet been elucidated. Only recently has immunohistochemical staining in formalin-fixed specimens become feasible. This is a major technical breakthrough since it is almost impossible to obtain fresh frozen specimens of coronary artery lesions of Kawasaki discase. In this paper, we compare immunohistochemical findings in coronary artery lesions with the corresponding coronary angiographic findings, and attempt to make inferences as to the mechanism of remodeling both in early and late phases of the disease based on the expression of vascular growth factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987345     DOI: 10.1536/jhj.41.245

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  12 in total

1.  Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.

Authors:  Lori B Daniels; Matthew S Tjajadi; Hannah H Walford; Susan Jimenez-Fernandez; Vera Trofimenko; Daryl B Fick; Hoang-Anh L Phan; Peter E Linz; Keshav Nayak; Andrew M Kahn; Jane C Burns; John B Gordon
Journal:  Circulation       Date:  2012-05-17       Impact factor: 29.690

2.  Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities.

Authors:  Cedric Manlhiot; Leonardo R Brandão; Zeeshanefatema Somji; Amy L Chesney; Catherine MacDonald; Rebecca C Gurofsky; Tarun Sabharwal; Nita Chahal; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2010-04-30       Impact factor: 1.655

3.  Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease.

Authors:  Cedric Manlhiot; Kyle Millar; Fraser Golding; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2009-12-19       Impact factor: 1.655

4.  Association of vascular endothelial growth factor C-634 g polymorphism in taiwanese children with Kawasaki disease.

Authors:  K-C Hsueh; Y-J Lin; J-S Chang; L Wan; Y-H Tsai; C-H Tsai; C-P Chen; F-J Tsai
Journal:  Pediatr Cardiol       Date:  2007-09-15       Impact factor: 1.655

5.  High Sensitivity C Reactive Protein (hs-CRP) in Adolescent and Young Adult Patients with History of Kawasaki Disease.

Authors:  Yung-Chuan Chen; Ching-Tsuen Shen; Nan-Koong Wang; Yi-Ling Huang; Hsin-Hui Chiu; Chun-An Chen; Shuenn-Nan Chiu; Ming-Tai Lin; Jou-Kou Wang; Mei-Hwan Wu
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

6.  Changes in coronary perfusion after occlusion of coronary arteries in Kawasaki disease.

Authors:  Ji Hee Kwak; Jinyoung Song; I-Seok Kang; June Huh; Heung-Jae Lee
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

7.  Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study.

Authors:  Jan Marc Orenstein; Stanford T Shulman; Linda M Fox; Susan C Baker; Masato Takahashi; Tricia R Bhatti; Pierre A Russo; Gary W Mierau; Jean Pierre de Chadarévian; Elizabeth J Perlman; Cynthia Trevenen; Alexandre T Rotta; Mitra B Kalelkar; Anne H Rowley
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

8.  Long-term outcome of coronary artery dilatation in Kawasaki disease.

Authors:  Najib Advani; Sudigdo Sastroasmoro; Teddy Ontoseno; Cuno Spm Uiterwaal
Journal:  Ann Pediatr Cardiol       Date:  2018 May-Aug

9.  Incidence Rate and Epidemiological and Clinical Aspects of Kawasaki Disease in Children of Maghrebi Origin in the Province of Quebec, Canada, Compared to the Country of Origin.

Authors:  Arbia Abir Gorrab; Anne Fournier; Asma Abed Bouaziz; Linda Spigelblatt; Rosie Scuccimarri; Ali Mrabet; Nagib Dahdah
Journal:  Glob Pediatr Health       Date:  2016-02-16

10.  Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study.

Authors:  Cristina Medeiros R de Magalhães; Fernanda Coutinho de Almeida; Lenora Gandolfi; Riccardo Pratesi; Natália Ribeiro de M Alves; Nicole Selleski; Renata Puppin Zandonadi; Eduardo Yoshio Nakano; Claudia B Pratesi
Journal:  Medicina (Kaunas)       Date:  2020-03-25       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.